PROVIDER PROFILE · NPI 1659560266
Guada Respicio DuqueM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
6,433
Unique beneficiaries
—
Total services
141,160
Distinct HCPCS
61
Medicare payment
$1.6M
Peer benchmark
Total Medicare services vs. 133 Rheumatology providers in MD — top quintile (cohort median 27,542).
PRESCRIBING · PART D · 2024
Total Rx claims
1,212
Beneficiaries
—
Total drug cost
$763K
Distinct drugs
26
Brand share
17.2%
Top prescribed drugs
Duloxetine Hcl147 claims
Hydroxychloroquine Sulfate114 claims
Gabapentin109 claims
Methotrexate Sodium106 claims
Leflunomide89 claims
QUALITY · MIPS · 2024
Final MIPS score
85.7
Quality
93.4
Cost
59.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$314
Payment records
6
By payment type
Food and Beverage$215
Education$99
Top paying entities
Food and Beverage$215
Education$99
REFERRAL NETWORK
Where Guada Respicio Duque's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 49 | 122 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE